S&P 500   5,007.30 (-0.08%)
DOW   37,893.17 (+0.31%)
QQQ   422.83 (-0.14%)
AAPL   166.82 (-0.13%)
MSFT   404.90 (+0.16%)
META   506.50 (+0.94%)
GOOGL   155.40 (-0.39%)
AMZN   178.78 (-0.25%)
TSLA   149.20 (-0.49%)
NVDA   846.50 (-0.02%)
AMD   154.33 (-0.48%)
NIO   3.87 (-3.25%)
BABA   68.49 (-0.57%)
T   16.25 (-0.49%)
F   12.05 (-0.08%)
MU   109.77 (-1.93%)
GE   152.90 (-0.03%)
CGC   7.60 (-2.94%)
DIS   111.77 (-0.59%)
AMC   2.89 (-1.03%)
PFE   25.41 (+0.08%)
PYPL   62.02 (-0.13%)
XOM   118.75 (+0.19%)
S&P 500   5,007.30 (-0.08%)
DOW   37,893.17 (+0.31%)
QQQ   422.83 (-0.14%)
AAPL   166.82 (-0.13%)
MSFT   404.90 (+0.16%)
META   506.50 (+0.94%)
GOOGL   155.40 (-0.39%)
AMZN   178.78 (-0.25%)
TSLA   149.20 (-0.49%)
NVDA   846.50 (-0.02%)
AMD   154.33 (-0.48%)
NIO   3.87 (-3.25%)
BABA   68.49 (-0.57%)
T   16.25 (-0.49%)
F   12.05 (-0.08%)
MU   109.77 (-1.93%)
GE   152.90 (-0.03%)
CGC   7.60 (-2.94%)
DIS   111.77 (-0.59%)
AMC   2.89 (-1.03%)
PFE   25.41 (+0.08%)
PYPL   62.02 (-0.13%)
XOM   118.75 (+0.19%)
S&P 500   5,007.30 (-0.08%)
DOW   37,893.17 (+0.31%)
QQQ   422.83 (-0.14%)
AAPL   166.82 (-0.13%)
MSFT   404.90 (+0.16%)
META   506.50 (+0.94%)
GOOGL   155.40 (-0.39%)
AMZN   178.78 (-0.25%)
TSLA   149.20 (-0.49%)
NVDA   846.50 (-0.02%)
AMD   154.33 (-0.48%)
NIO   3.87 (-3.25%)
BABA   68.49 (-0.57%)
T   16.25 (-0.49%)
F   12.05 (-0.08%)
MU   109.77 (-1.93%)
GE   152.90 (-0.03%)
CGC   7.60 (-2.94%)
DIS   111.77 (-0.59%)
AMC   2.89 (-1.03%)
PFE   25.41 (+0.08%)
PYPL   62.02 (-0.13%)
XOM   118.75 (+0.19%)
S&P 500   5,007.30 (-0.08%)
DOW   37,893.17 (+0.31%)
QQQ   422.83 (-0.14%)
AAPL   166.82 (-0.13%)
MSFT   404.90 (+0.16%)
META   506.50 (+0.94%)
GOOGL   155.40 (-0.39%)
AMZN   178.78 (-0.25%)
TSLA   149.20 (-0.49%)
NVDA   846.50 (-0.02%)
AMD   154.33 (-0.48%)
NIO   3.87 (-3.25%)
BABA   68.49 (-0.57%)
T   16.25 (-0.49%)
F   12.05 (-0.08%)
MU   109.77 (-1.93%)
GE   152.90 (-0.03%)
CGC   7.60 (-2.94%)
DIS   111.77 (-0.59%)
AMC   2.89 (-1.03%)
PFE   25.41 (+0.08%)
PYPL   62.02 (-0.13%)
XOM   118.75 (+0.19%)
Free Trial
EPA:DIM

Sartorius Stedim Biotech (DIM) Stock Price, News & Analysis

→ The A.I. story nobody is telling you (Read ASAP) (From TradeSmith) (Ad)
Free DIM Stock Alerts
€209.60
-39.00 (-15.69%)
(As of 04/18/2024 ET)
Compare
Today's Range
€201.20
▼
€219.70
50-Day Range
€240.20
▼
€280.00
52-Week Range
N/A
Volume
299,152 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisChartHeadlines
DIM stock logo

About Sartorius Stedim Biotech Stock (EPA:DIM)

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides cell cultivation, fermentation, separation, purification, and fluid management services; biolayer interferometry instruments; microbiology enumeration, sterility testing, and air monitoring instruments; pipette products; sensors and analyzers; biomolecule analysis tools; flow cytometry; batch and intensified chromatography systems; lab data and fleet management software; live cell imaging and analysis; surface plasmon resonance solutions; and weighing products. In addition, the company offers data analytics software for modeling and optimizing processes of biopharmaceutical development and production; process automation platform and software; and develops and produces transfection, as well as other DNA/RNA delivery reagents and plasmid DNA. It serves manufacturers of medications, vaccines, foods, and chemicals, as well as research and development laboratories. The company was incorporated in 1978 and is headquartered in Aubagne, France. As of December 31, 2023, Sartorius Stedim Biotech S.A. operates as a subsidiary of Sartorius AG.

DIM Stock Price History

DIM Stock News Headlines

April 19, 2024 | americanbankingnews.com
Sartorius Stedim Biotech (EPA:DIM) Stock Price Down 1.5%
April 18, 2024 | finanznachrichten.de
Sartorius Stedim Biotech publishes unaudited -2-
April 19, 2024 | Gold Safe Exchange (Ad)
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
April 18, 2024 | markets.businessinsider.com
Sartorius Stedim Biotech publishes unaudited first quarter results for 2024
April 1, 2024 | msn.com
Sartorius Stedim Biotech S.A. goes ex dividend tomorrow
March 26, 2024 | markets.businessinsider.com
Resolutions of the Annual Shareholders’ Meeting of Sartorius Stedim Biotech S.A.
March 25, 2024 | msn.com
France stocks lower at close of trade; CAC 40 down 0.00%
February 7, 2024 | markets.businessinsider.com
Board of Directors of Sartorius Stedim Biotech resolves to propose a dividend of 0.69 euros per share to the Annual Shareholders’ Meeting
April 19, 2024 | Gold Safe Exchange (Ad)
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
February 6, 2024 | markets.businessinsider.com
EQS-Adhoc: SARTORIUS AG: Sartorius launches placement of up to 200 million euros of treasury preference shares through accelerated bookbuilding
February 6, 2024 | finanznachrichten.de
Sartorius Stedim Biotech S.A. announces an -2-
January 30, 2024 | morningstar.com
Sartorius Stedim Biotech SA
January 26, 2024 | reuters.com
Sartorius aims to grow again in 2024 after business slump
January 26, 2024 | finanznachrichten.de
Sartorius Stedim Biotech publishes preliminary, -3-
January 25, 2024 | uk.finance.yahoo.com
Sartorius Stedim Biotech S.A. (DIM.PA)
December 27, 2023 | msn.com
France stocks mixed at close of trade; CAC 40 up 0.04%
December 20, 2023 | markets.businessinsider.com
Valneva Shareholders Approve EGM Resolutions Including the Transition to a Board of Directors
December 5, 2023 | barrons.com
European Pharmas With New Drugs Hold Most Promise in 2024
November 21, 2023 | benzinga.com
Single Use Assemblies Market worth $5.2 billion by 2028
November 7, 2023 | thestreet.com
Sartorius Stedim Biotech S.A. ADR
October 19, 2023 | washingtonpost.com
Short-Sellers Sink One of Europe’s Hottest Stocks
October 16, 2023 | msn.com
Middle East Tensions: The Ripple Effect on Global Stock Markets
October 13, 2023 | marketwatch.com
US Futures Rise Slightly, European Stocks Mixed
October 13, 2023 | marketwatch.com
Sartorius's Shares Drop on Outlook Cut, Preliminary 3Q Declines
October 12, 2023 | markets.businessinsider.com
Sartorius Stedim Biotech SA: Sartorius Stedim Biotech pre-announces preliminary 9-month results and lowers forecast for 2023
October 10, 2023 | finanznachrichten.de
Single Use Assemblies Market worth $5.2 billion | MarketsandMarkets
September 13, 2023 | msn.com
France stocks mixed at close of trade; CAC 40 down 0.35%
See More Headlines
Receive DIM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sartorius Stedim Biotech and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
EPA
Sector
Medical
Industry
Medical Instruments & Supplies
Sub-Industry
N/A
Current Symbol
EPA:DIM
CUSIP
N/A
CIK
N/A
Web
www.sartorius.com
Phone
33 4 42 84 56 00
Fax
N/A
Employees
10,662
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
Investing Strategies To Help Grow Your Retirement Income Cover
Investing Strategies To Help Grow Your Retirement Income

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Dr. Rene Faber (Age 49)
    CEO & DIrector
    Comp: $540k
  • Mr. Rainer Lehmann (Age 49)
    CFO & Member of Executive Board
  • Ms. Petra Muller
    Head of Investor Relations
  • Ms. Petra Kirchhoff (Age 55)
    Head of Corporate Communications & IR
  • Olivier Guitard
    Head of Controlling BPS

Key Competitors

View All Competitors

DIM Stock Analysis - Frequently Asked Questions

How have DIM shares performed in 2024?

Sartorius Stedim Biotech's stock was trading at €239.50 at the beginning of the year. Since then, DIM shares have decreased by 12.5% and is now trading at €209.60.
View the best growth stocks for 2024 here.

What other stocks do shareholders of Sartorius Stedim Biotech own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sartorius Stedim Biotech investors own include Allena Pharmaceuticals (ALNA), Ampliphi Biosciences (APHB), Arbutus Biopharma (ABUS), Aurora Cannabis (ACBFF), AcelRx Pharmaceuticals (ACRX), Aldeyra Therapeutics (ALDX), Apellis Pharmaceuticals (APLS), Aquinox Pharmaceuticals (AQXP).

This page (EPA:DIM) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
The “Perfect Storm” for Gold
Gold Safe Exchange
Biden’s $374B Giveaway Into This Sector
DTI
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
Paradigm Press
Your Money is Not Safe
American Alternative
He Is Giving Away Bitcoin
Crypto Swap Profits
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research